This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Pharma Mar, S.a.. Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Alfredo Pastor Del Castillo
Introduction
Alfredo Pastor Del Castillo is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumoral compounds. His work is characterized by a commitment to advancing medical science and improving treatment options for patients.
Latest Patents
Alfredo Pastor Del Castillo holds a patent for "Antitumoral analogs of lamellarins." This patent introduces new lamellarins represented by the general formula III or a pharmaceutically acceptable salt, derivative, prodrug, or stereoisomer thereof. This innovation is crucial in the ongoing battle against cancer, providing new avenues for therapeutic intervention.
Career Highlights
Pastor Del Castillo is associated with Pharma Mar, S.A., a company renowned for its focus on marine-derived pharmaceuticals. His work at Pharma Mar has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His dedication to innovation has positioned him as a key figure in the field.
Collaborations
Throughout his career, Alfredo has collaborated with esteemed colleagues such as José Antonio Jiménez Guerrero and Christian Bailly. These partnerships have fostered a collaborative environment that enhances the potential for innovative breakthroughs in cancer treatment.
Conclusion
Alfredo Pastor Del Castillo's contributions to the field of pharmaceuticals, particularly through his patent on antitumoral analogs, highlight his role as an influential inventor. His work continues to inspire advancements in medical science and offers hope for improved cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
